Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form
As of April 1st VIVO Scientific Profiles will no longer updated for faculty, and the link to VIVO will be removed from the library website. Faculty profile pages will continue to be updated via Interfolio. VIVO will continue being used behind the scenes to update graduate student profiles. Please contact helplib@scripps.edu if you have questions.
How to download citations from VIVO | Alternative profile options

Activation of PPARdelta alters lipid metabolism in db/db mice

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Leibowitz, M. D.
  • Fievet, C.
  • Hennuyer, N.
  • Peinado-Onsurbe, J.
  • Duez, H.
  • Berger, J.
  • Cullinan, C. A.
  • Sparrow, C. P.
  • Baffic, J.
  • Berger, G. D.
  • Santini, C.
  • Marquis, R. W.
  • Tolman, R. L.
  • Smith, Roy
  • Moller, D. E.
  • Auwerx, J.

publication date

  • May 2000

journal

  • FEBS Letters  Journal

abstract

  • Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors, which heterodimerize with the retinoid X receptor and bind to peroxisome proliferator response elements in the promoters of regulated genes. Despite the wealth of information available on the function of PPARalpha and PPARgamma, relatively little is known about the most widely expressed PPAR subtype, PPARdelta. Here we show that treatment of insulin resistant db/db mice with the PPARdelta agonist L-165041, at doses that had no effect on either glucose or triglycerides, raised total plasma cholesterol concentrations. The increased cholesterol was primarily associated with high density lipoprotein (HDL) particles, as shown by fast protein liquid chromatography analysis. These data were corroborated by the chemical analysis of the lipoproteins isolated by ultracentrifugation, demonstrating that treatment with L-165041 produced an increase in circulating HDL without major changes in very low or low density lipoproteins. White adipose tissue lipoprotein lipase activity was reduced following treatment with the PPARdelta ligand, but was increased by a PPARgamma agonist. These data suggest both that PPARdelta is involved in the regulation of cholesterol metabolism in db/db mice and that PPARdelta ligands could potentially have therapeutic value.

subject areas

  • Acetates
  • Adipose Tissue
  • Animals
  • Blood Glucose
  • Cholesterol
  • Chromatography, Liquid
  • DNA-Binding Proteins
  • Ligands
  • Lipids
  • Lipoprotein Lipase
  • Lipoproteins
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Phenols
  • Phenoxyacetates
  • Receptors, Cytoplasmic and Nuclear
  • Transcription Factors
  • Triglycerides
  • Ultracentrifugation
scroll to property group menus

Research

keywords

  • lipid metabolism
  • peroxisome proliferator-activated receptor
  • peroxisome proliferator-activated receptor delta agonist
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0014-5793

Digital Object Identifier (DOI)

  • 10.1016/s0014-5793(00)01554-4

PubMed ID

  • 10818235
scroll to property group menus

Additional Document Info

start page

  • 333

end page

  • 336

volume

  • 473

issue

  • 3

©2022 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support